APSR logo
APSR logo

Previous ESAP
ESAP logo



Hong Kong

JW Marriott Hotel
29 March 2008

Tuberculosis in the Asia-Pacific Region in the 21st Century

After this ESAP, the APSR Secretary General reported the following:

Recently, the APSR has supported the Hong Kong Thoracic Society and the American College of Chest Physicians (Hong Kong and Macau Chapter) in organizing an Educational Seminar of the Asian Pacific Society of Respirology (ESAP): Tuberculosis in the Asia-Pacific region in the 21st Century (March 29, 2008).

I am very grateful to have had the opportunity to join the seminar personally, and it was a really successful event. There were about 400 participants and outstanding speakers from Japan, U.S.A., China and Hong Kong. The topics covered the local epidemiology in Asia-Pacific region, an overview of tuberculosis control in China, and the impact tuberculosis has on lifestyles. Other emergent topics included the recent advances in diagnosis of tuberculosis infection, immunopathogenesis and the potential for vaccine development, as well as the multidrug-resistant tuberculosis in Asia-Pacific Region. The speakers explored in depth the local regional problems, the future possibilities to improve diagnosis, contemporary treatment, and chemotherapy.

This Educational Seminar was also a great success in raising people's concerns about this disease, helping them to know more about how it might affect people's life, and what could people and the governments do to combat this disease. As tuberculosis is a prevailing disease in Asia-Pacific, I believe it was right for APSR to assist this event. It is our obligation to improve people's health and I hope this is a good start on lung healthcare in Asia-Pacific region.

Pan-Chyr Yang MD, PhD.
Secretary General
Asian Pacific Society of Respirology

The following announced the ESAP held at the JW Marriott Hotel Hong Kong, one day before the Annual Scientific Meeting 2008 (ASM 2008) of the Hong Kong Thoracic Society (HKTS) and the American College of Chest Physicians (Hong Kong & Macau Chapter) (ACCP).

Tuberculosis in the Asia-Pacific Region in the 21st Century

This ESAP is being co-organized by the HKTS and the ACCP, with support from the APSR and the Hong Kong Tuberculosis, Chest and Heart Diseases Association. It is a one-day meeting and we are anticipating about 150 doctors and allied health professionals attending the Seminar.

We are very pleased to have renowned speakers from China, Japan and USA to address on this issue as well as our local experts. Your attendance will be assured to be a valuable one.

Immediately following the ESAP, on 30 March 2008, we will have our Annual Scientific Meeting 2008 (ASM 2008) co-organized by the HKTS and the ACCP. This is an annual scientific activity of the two societies. Each year, we have about 400 doctors and allied health professionals attending the meeting. We have offered a special rate for those interested to attend both meetings.

We look forward to seeing you at the meeting.

Dr. Bing Lam
Dr. Poon-chuen Wong

09:30‑09:35Opening Remarks
09:30‑12:00Symposium I: Epidemiology, Diagnosis and Pathogenesis of Tuberculosis
Epidemiology of Tuberculosis in Asia-Pacific Region
T Mori, Research Institute of Tuberculosis, Japan Anti-tuberculosis Association, Japan
Impact of Lifestyle Factors on Tuberculosis
CC Leung, Tuberculosis & Chest Service, Centre for Health Protection, Department of Health, Hong Kong
Tuberculosis Control in China: Current Issues and Future Prospects
LX Wang, Center for Disease Control & Prevention, National Centre of Tuberculosis Control & Prevention, China
Advances in Diagnosis of Tuberculosis Infection and Disease
NW Schluger, Division of Pulmonary, Allergy & Critical Care Medicine, Columbia University Medical Center, USA
Immunopathogenesis of Tuberculosis: Implications for Vaccine Development
Y Zhang, Department of Molecular Microbiology & Immunology, Bloomberg School of Public Health, Johns Hopkins University, USA
13:30‑15:55Symposium II: Update in Management of Tuberculosis
Treatment of HIV-related Tuberculosis: Outstanding Issues
WJ Burman, Denver Public Health & Department of Medicine, University of Colorado Health Services, USA
Treatment of Tuberculosis in Presence of Renal and Hepatic Impairment
KS Chan, Department of Medicine & Geriatrics, Haven of Hope Hospital, Hong Kong
Management of Multidrug-resistant Tuberculosis in Asia-Pacific Region
WW Yew, Tuberculosis & Chest Unit, Grantham Hospital, Hong Kong
Rifamycins and Fluoroquinolones in Treatment of Tuberculosis: Current Status and Future Directions
AA Vernon, Clinical & Health Systems Research Branch, Division of Tuberculosis Elimination, Centers for Disease Control & Prevention, USA
Development of New Anti-tuberculosis Drugs: Its Relevance Worldwide and in Asia-Pacific Region
CM Tam, Tuberculosis & Chest Service, Centre for Health Protection, Department of Health, Hong Kong
15:55‑16:00Closing Remarks

Academic accreditations

Continuous medical education (CME) accreditation is under application from relevant Colleges in Hong Kong. For details, please contact the Secretariat.

Registration fee

ESAP2008 only: Members of HKTS / ACCP / APSR: HK$100
Non-members: HK$780 / US$100
Both ESAP2008 & ASM2008:Members of HKTS / ACCP: HK$200
Non-members:HK$1,000 / US$125


Complete the registration form (jpg) and return it with payment to the Secretariat before 15 March 2008 (first-come-first-served). Please make cheque payable to "Hong Kong Thoracic Society Limited".

On-site registration will not be accepted.


Ms. Chloe Wong
CMPMedica Pacific Limited
Unit 901 - 903, AXA Centre, 151 Gloucester Road,
Wanchai, Hong Kong
Tel: (852) 2155 8557 / 2559 5888
Fax: (852) 2559 6910
E-mail: meeting.hk@asia.cmpmedica.com